Wilms' tumor: past, present and (possibly) future. (Q36381288)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16445377%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

review article

1 reference

title

Wilms' tumor: past, present and (possibly) future (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16445377%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16445377%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Franca Fossati Bellani

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16445377%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

1 February 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16445377%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Anticancer Therapy

16 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16445377%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16445377%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16445377%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

249-258

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16445377%20AND%20SRC:MED&resulttype=core&format=json

The treatment of stages I-IV favorable histology Wilms' tumor.

16 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.2.249

Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.2.249

Wilms' tumor. Overview of National Wilms' Tumor Study Group results

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.2.249

Pre‐ or post‐operative treatment for sWilms tumor? who, what, when, where, how, why—and which

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.2.249

Management of Wilms' tumour: current practice and future goals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.2.249

Controversies and advances in the management of Wilms' tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.2.249

The role of preoperative chemotherapy in the management of Wilms' tumor. The SIOP studies. International Society of Pediatric Oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.2.249

Ifosfamide, carboplatin and etoposide in children with poor-risk relapsed Wilms' tumor: a Children's Cancer Group report

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.2.249

High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.2.249

Treatment of relapsed Wilms' tumor with high-dose therapy and autologous hematopoietic stem-cell rescue: the experience at Children's Memorial Hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.2.249

Focal versus diffuse anaplasia in Wilms tumor--new definitions with prognostic significance: a report from the National Wilms Tumor Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.2.249

New developments in the pathology of Wilms tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.2.249

Histological analysis of aggressiveness and responsiveness in Wilms' tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.2.249

Recent advances in pediatric renal neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.2.249

Clear cell sarcoma of the kidney: a review of 351 cases from the National Wilms Tumor Study Group Pathology Center

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.2.249

Revised International Society of Paediatric Oncology (SIOP) working classification of renal tumors of childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.2.249

Clinical impact of histologic subtypes in localized non-anaplastic nephroblastoma treated according to the trial and study SIOP-9/GPOH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.2.249

Recent advances in Wilms tumor genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.2.249

Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.2.249

Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.2.249

Loss of heterozygosity on chromosome 16 in sporadic Wilms' tumour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.2.249

Allele loss in Wilms tumors of chromosome arms 11q, 16q, and 22q correlate with clinicopathological parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.2.249

Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.2.249

Chromosome arm 16q in Wilms tumors: unbalanced chromosomal translocations, loss of heterozygosity, and assessment of the CTCF gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.2.249

The treatment of Wilms' tumor. Results of the national Wilms' tumor study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.2.249

Treatment of children with stage IV favorable histology Wilms tumor: a report from the National Wilms Tumor Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.2.249

Significance and management of computed tomography detected pulmonary nodules: a report from the National Wilms Tumor Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.2.249

Radiotherapy in the SIOP (International Society of Pediatric Oncology) nephroblastoma studies: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.2.249

Preoperative versus postoperative radiotherapy, single versus multiple courses of actinomycin D, in the treatment of Wilms' tumor. Preliminary results of a controlled clinical trial conducted by the International Society of Paediatric Oncology (S.I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.2.249

The treatment of Wilms' tumour: results of the United Kingdom Children's cancer study group (UKCCSG) second Wilms' tumour study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.2.249

The role of biopsy in the diagnosis of renal tumors of childhood: Results of the UKCCSG Wilms tumor study 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.2.249

Quality assessment for Wilms' tumor: a report from the National Wilms' Tumor Study-5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.2.249

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.2.249

The relationship between microsubstaging variables, age at diagnosis, and tumor weight of children with stage I/favorable histology Wilms' tumor. A report from the National Wilms' Tumor study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.2.249

Doxorubicin for favorable histology, Stage II-III Wilms tumor: results from the National Wilms Tumor Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.2.249

Outcome of patients with stage III or inoperable WT treated on the second United Kingdom WT protocol (UKWT2); a United Kingdom Children's Cancer Study Group (UKCCSG) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.2.249

Treatment of childhood Wilms' tumor without radiotherapy in Nicaragua

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.2.249

Wilms tumor locus on 11p13 defined by multiple CpG island-associated transcripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.2.249

Refinement within single yeast artificial chromosome clones of a minimal region commonly deleted on the short arm of chromosome 7 in Wilms tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.2.249

Mapping of a Putative Tumor Suppressor Locus to Proximal 7p in Wilms Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.2.249

21 January 2018

Identifiers

DOI

10.1586/14737140.6.2.249

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16445377%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference